Read Discussion Below Explained for Students (Easy Guide)

This type of question evaluates analytical and critical thinking skills.

What This Question Is About

This question relates to read discussion below and requires a structured academic response.

How to Approach This Question

Use appropriate theories and support your answer with clear reasoning.

Key Explanation

This topic involves read discussion below. A strong answer should include explanation, application, and examples.

Original Question

Read the discussion Below: Many antipsychotic medications, particularly first-generation agents such as haloperidol and chlorpromazine, are associated with a group of side effects known as extrapyramidal symptoms (EPS). These symptoms arise because these medications block dopamine receptors not only in brain pathways related to psychotic symptoms but also in regions involved in motor control. EPS can manifest in several distinct forms. Acute dystonia involves sudden, involuntary muscle contractions that may cause abnormal postures, neck twisting, eye deviation, or jaw clenching, often requiring urgent intervention. Akathisia is characterized by a subjective feeling of inner restlessness accompanied by observable motor movements such as pacing, fidgeting, or an inability to remain seated. Parkinsonism, another common form, includes symptoms such as muscular rigidity, resting tremor, slowed movement (bradykinesia), and a shuffling gait, resembling idiopathic Parkinson’s disease. Tardive dyskinesia (TD) is a late-onset movement disorder marked by repetitive, involuntary movements, typically of the face, lips, or tongue, and may persist or worsen even after the antipsychotic medication is reduced or discontinued. Early recognition and appropriate management of EPS are crucial for minimizing discomfort, preventing long-term complications, and promoting medication adherence. Extrapyramidal symptoms (EPS) do not have any functional benefit for the individual; they are unintended side effects of antipsychotic treatment. These symptoms occur because antipsychotic medications block dopamine receptors in multiple brain pathways. While dopamine blockade in the mesolimbic pathway helps reduce positive psychotic symptoms such as hallucinations and delusions, the same mechanism also affects the nigrostriatal pathway, which is responsible for regulating voluntary motor control. As a result, EPS reflects the unintended suppression of normal motor function due to the medication’s pharmacological action. Thankfully, there are good options for managing these side effects. Treatment usually depends on which specific movement issue someone is having. For sudden, painful muscle spasms (acute dystonia), quick relief is often found by giving an anticholinergic medication, like benztropine or diphenhydramine, which relaxes the muscles. If someone develops akathisia, doctors might lower the antipsychotic dose if possible and add a beta-blocker like propranolol or sometimes a mild sedative such as lorazepam to help with the sense of inner agitation. For Parkinson-like symptoms, adjusting the dose or switching to a newer antipsychotic with a lower risk for EPS often helps. Adding an anticholinergic or medications like amantadine can also relieve stiffness and tremors. Tardive dyskinesia is trickier because it can be hard to reverse once it sets in. The best approach is prevention: using the lowest effective dose of medication and monitoring for early signs. If TD does appear, switching to an antipsychotic with a lower risk and using specialized medications called VMAT2 inhibitors (like valbenazine or deutetrabenazine) can reduce the movements. Counselors play an important role in supporting clients who are prescribed antipsychotic medications. Due to their regular and direct contact with clients, counselors are well-positioned to observe early signs of extrapyramidal symptoms (EPS), such as mild tremors, restlessness, or involuntary facial movements, which clients may not voluntarily report. Early detection enables timely referral and coordination with prescribing providers to address these side effects effectively. Counselors also contribute by providing psychoeducation to clients and their families, helping them understand the nature, causes, and treatment options for EPS, which can reduce misunderstandings and improve adherence to prescribed treatment. Additionally, counselors can facilitate communication between clients and medical professionals, advocate for necessary medication adjustments, and offer appropriate emotional support to help clients manage any distress related to involuntary movements. By monitoring for side effects, providing education, and coordinating care, counselors help promote treatment continuity and overall well-being. APA References American Psychiatric Association. (2022). The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia, third edition. American Psychiatric Publishing. https://doi.org/10.1176/appi.books.9780890424841 Muench, J., & Hamer, A. M. (2010). Adverse effects of antipsychotic medications. American Family Physician, 81(5), 617-622. Retrieved from https://www.aafp.org/pubs/afp/issues/2010/0301/p617.html Muench, J., & Gorman, J. M. (2017). Extrapyramidal side effects of antipsychotic treatment: Scope of problem and management. Psychiatric Times. Retrieved from https://www.psychiatrictimes.com/view/extrapyramidal-side-effects-antipsychotic-treatment-scope-problem-and-management Keepers, G. A., Fochtmann, L. J., Anzia, J. M., et al. (2020). The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry, 177(9), 868-872. https://doi.org/10.1176/appi.ajp.2020.177901 Sadock, B. J., Sadock, V. A., & Ruiz, P. (2015). Kaplan & Sadock’s synopsis of psychiatry: Behavioral sciences/clinical psychiatry (11th ed.). Wolters Kluwer. Marder, S. R. (2019). Antipsychotic medications and their side effects. In B. J. Sadock, V. A. Sadock, & P. Ruiz (Eds.), Kaplan & Sadock’s comprehensive textbook of psychiatry (10th ed., pp. 2967-2985). Wolters Kluwer. Then, answer the following: Add to the post by discussing two additional issues not addressed by the post, and state why these are important to know. The post must provide in-text citations and references. Formatted properly using APA guidelines and appropriate third-person grammar, with at least 1 peer-reviewed article that could add to the paper, and at least 2 of the references listed below: Preston, J.D., O’Neal, J.H., & Talaga, M.C. (2025). Handbook of Clinical Psychopharmacology for Therapists (10th ed.). New Harbinger Publications, Inc. Preston, J.D., O’Neal, J.H., & Talaga, M.C. (2021). Child and Adolescent Clinical Psychopharmacology Made Simple (4th ed.). New Harbinger Publications, Inc. Shannon, M.T., Wilson, B.A., & Shields, K. (2018). Pearson Health Professional’s Drug Guide 2017-2018. Pearson/Prentice Hall.

******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."